Riskpilot← Back to searchSign inGet full accessRYEN ØRE-NESE-HALS AS
ASActiveOrg 897655632Sandstuveien 60A, 1184 OsloMedical specialists activities · NACE 8622Est. 20116 employees
Revenue 2025
NOK 4,4M
-9% vs 2024
EBITDA margin
3.0%
+9% vs 2024
Equity ratio
23.5%
Financial strength
Net profit 2025
NOK -11K
-1513% vs 2024
| Revenue | NOK 4,4M | -9% |
| EBITDA | NOK 133K | +9% |
| Net profit | NOK -11K | -1513% |
| Total assets | NOK 1,2M | +49% |
| Equity | NOK 274K | -4% |
| Employees | 6 | — |
Legal name
RYEN ØRE-NESE-HALS AS
Org number
897655632
Legal form
Aksjeselskap
NACE code
8622 · Medical specialists activities
Founded
30. november 2011
Share capital
NOK 200 000
Employees
6 (FTE)
VAT registered
No
Audit selected
No
Last report
2025-12-31
Financial year
January – December
Signatory rights
Styret i fellesskap.
Company purpose
Drift av kontorfellesskap for spesialistlegetjenester innen øre-nese-hals.
Address
Sandstuveien 60A, 1184 Oslo
Phone
+4722805500
Email
post@onhbrynseng.nhn.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 6 548 | 6 893 | 6 444 | 4 800 | 4 391 |
| Staff expenses | −3 579 | −3 603 | −3 798 | −2 423 | −1 974 |
| EBITDA | 591 | 520 | −109 | 122 | 133 |
| Depreciation & amort. | −84 | −95 | −112 | −113 | −103 |
| EBIT | 507 | 425 | −221 | 9 | 31 |
| Net financials | −0 | −1 | −2 | 0 | −19 |
| Profit before tax | 507 | 424 | −224 | 9 | 12 |
| Tax | 111 | 94 | −43 | 10 | 23 |
| Net profit | 395 | 330 | −181 | −1 | −11 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 874 | 1 196 | 933 | 783 | 1 168 |
| Equity | 136 | 466 | 286 | 285 | 274 |
| Long-term debt | 0 | 0 | 0 | 0 | 475 |
| Short-term debt | 738 | 730 | 647 | 498 | 419 |
| Total debt | 738 | 730 | 647 | 498 | 894 |
EBITDA margin
3.0%
This company
15.8%
Market median
-81% vs market
20212025
Equity ratio
23.5%
This company
38.2%
Market median
-38% vs market
20212025
Return on equity
-4.0%
This company
18.4%
Market median
-122% vs market
20212025
Net profit margin
-0.3%
This company
8.1%
Market median
-104% vs market
20212025
Asset turnover
3.76×
This company
1.12×
Market median
+236% vs market
20212025
Debt / equity
3.26×
This company
0.62×
Market median
-426% vs market
20212025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2025-01-01 – 2025-12-31
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
| Name | Role | Member since |
|---|---|---|
| Former (2) | ||
BV Deputy Member | Deputy Member | 2015 – 2021 |
KF Chief Executive Officer | Chief Executive Officer | 2015 – 2021 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairman | 2023 | |
| Deputy Chairman | 2023 | |
| Former (1) | ||
| Board of Directors | 2021 – 2022 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 50% | 50% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Tympani As
RYEN ØRE-NESE-HALS AS Board members of RYEN ØRE-NESE-HALS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Børge Vegard Tryving | Deputy Member | 0 companies |
| Ketil Fredrik Olsholt | Chief Executive Officer | 0 companies |
| Julie Julsrud Titterud | Board of Directors | 0 companies |
| Knut-Espen Titterud | Chairman | 0 companies |
| Sudeep Mukerji | Deputy Chairman | 0 companies |